Research
Promising drug for treating brain tumors stemming from breast cancer
July 30, 2025
“We knew that the drug has been effective in the treatment of breast cancer, but its usefulness in the treatment of resulting brain tumors has been unclear. Our trial, however, revealed that it could achieve concentrations of inhibitors inside the tumors sufficient to benefit patients, and with minimal side effects, which is very promising for […]
Breaking new ground with BRCA1 research at UT Health San Antonio
July 30, 2025
A study led by the UT Health San Antonio sheds light on a novel role of breast cancer gene 1 (BRCA1) in tumor suppression for breast and ovarian cancers. Individuals with inherited mutations in BRCA1 are predisposed to breast, ovarian and other cancers. BRCA1 helps prevent cancer by repairing damaged DNA, but how it does […]
UT Health San Antonio awarded $12.6 million grant for cancer research, understanding drug resistance
July 30, 2025
“This investment in research is a commitment to pioneering treatments in cancer care. The funding supports our mission to make significant strides in bringing hope and fighting cancer.” – Lei Zheng, MD, PhD, executive director of Mays Cancer Center. The University of Texas Health Science Center at San Antonio received a collaborative $12.6 million […]
UT Health San Antonio’s world-renowned expert in BRCA research honored for global contributions
July 30, 2025
Patrick Sung, DPhil, director of The University of Texas Health Science Center at San Antonio’s Greehey Children’s Cancer Research Institute and associate dean for research at UT Health San Antonio, is the latest recipient of the 2024 Basser Global Prize. A leading researcher in DNA damage repair and cancer biology, Sung has been awarded the […]
Mays Cancer Center identifies possible markers to detect metastatic lung cancer sooner
July 30, 2025
Researchers at Mays Cancer Center at The University of Texas Health Science Center at San Antonio have identified protein markers that could signal the development of metastatic lung cancer sooner – making it possible for new treatment. The findings led to a five-year, $1.6 million grant from the National Cancer Institute of the National Institutes […]
Mays Cancer Center partners with American Cancer Society to diagnose lung cancer sooner in South Texans
July 30, 2025
“This support is invaluable in helping our multidisciplinary team provide early detection and life-saving care to those at risk. We are improving outcomes and saving lives in the fight against lung cancer in a way that no other integrated academic health system in our region can do.” – Ramon Cancino, MD, MBA, MS, FAACP, executive […]
Gene-mutation pathway discovery paves way for targeted blood cancer therapies
July 30, 2025
About 30% of people with myeloid malignancy diseases have a mutation in a gene called tet methylcytosine dioxygenase 2 (TET2). This gene is known to have a tumor-suppressive function. “There currently is no specific, targeted treatment or therapy for these TET2-mutated cancers. This pathway opens a door for targeted therapeutics and targeted prevention,” said Mingjiang […]
UT Health San Antonio creates innovative method for advancing understanding of pancreatic cancer
July 30, 2025
“Learning how to prevent cancers from happening or figuring out how to stop them in their early stages is potentially more important than treatment itself. For pancreatic cancer, the biggest problem is that we find the cancer too late.” – Pei Wang, PhD, associate professor in the Department of Cell Systems and Anatomy at UT […]
A year of transformative progress
May 13, 2023
UT Health San Antonio’s Joe R. and Teresa Lozano Long School of Medicine Dean Robert Hromas, MD, identifies four areas of focus of the Mays Cancer Center in its quest to end cancer for communities in South Texas and beyond.
The biology of cancer
May 13, 2023
Mays Cancer Center researchers are making significant strides in understanding risk factors and conditions that cause cancers to develop and progress and assessing impacts on the health and recovery of patients with cancer.
Promising compound kills range of hard-to-treat cancers
May 13, 2023
Ratna Vadlamudi, PhD, a professor of obstetrics and gynecology at the Mays Cancer Center, is researching compounds that can target cancer cells to stop their growth.
New discoveries in pediatric cancer research
May 13, 2023
The findings from recent research studies in pediatric cancer offer hope for drug development.